| 0 |
NEONATAL SINUS BRADYCARDIA |
1 |
0.2000 |
| 1 |
REBOUND TACHYCARDIA |
3 |
0.0938 |
| 2 |
CYSTINOSIS |
1 |
0.0476 |
| 3 |
POLYSEROSITIS |
17 |
0.0399 |
| 4 |
GLIOSIS |
17 |
0.0396 |
| 5 |
PROCTECTOMY |
9 |
0.0327 |
| 6 |
OVARIAN FAILURE |
17 |
0.0318 |
| 7 |
CHRONOTROPIC INCOMPETENCE |
2 |
0.0238 |
| 8 |
ILEOSTOMY CLOSURE |
7 |
0.0209 |
| 9 |
ELECTROCARDIOGRAM R ON T PHENOMENON |
1 |
0.0200 |
| 10 |
POUCHITIS |
17 |
0.0197 |
| 11 |
CARDIAC PERFUSION DEFECT |
1 |
0.0189 |
| 12 |
PREMATURE MENOPAUSE |
17 |
0.0184 |
| 13 |
SOMATIC SYMPTOM DISORDER |
17 |
0.0157 |
| 14 |
ATRIAL PRESSURE INCREASED |
1 |
0.0132 |
| 15 |
INTESTINAL ANASTOMOSIS |
7 |
0.0109 |
| 16 |
ANTIPHOSPHOLIPID SYNDROME |
17 |
0.0106 |
| 17 |
SUPERIOR VENA CAVA OCCLUSION |
1 |
0.0079 |
| 18 |
VENOUS THROMBOSIS LIMB |
16 |
0.0077 |
| 19 |
PROPOFOL INFUSION SYNDROME |
4 |
0.0057 |
| 20 |
HEPATIC ENZYME DECREASED |
2 |
0.0045 |
| 21 |
PERIPHERAL VEIN THROMBOSIS |
1 |
0.0042 |
| 22 |
RIB DEFORMITY |
1 |
0.0039 |
| 23 |
LOCAL ANAESTHETIC SYSTEMIC TOXICITY |
4 |
0.0038 |
| 24 |
CARDIAC TAMPONADE |
17 |
0.0036 |
| 25 |
ILEOSTOMY |
9 |
0.0035 |
| 26 |
TACHYCARDIA PAROXYSMAL |
1 |
0.0034 |
| 27 |
ARRHYTHMIC STORM |
1 |
0.0030 |
| 28 |
NORMAL NEWBORN |
15 |
0.0028 |
| 29 |
ELECTROCARDIOGRAM QRS COMPLEX SHORTENED |
1 |
0.0026 |
| 30 |
OESOPHAGEAL INJURY |
1 |
0.0026 |
| 31 |
SARCOPENIA |
1 |
0.0023 |
| 32 |
THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0022 |
| 33 |
LIPIDS INCREASED |
4 |
0.0020 |
| 34 |
PULSELESS ELECTRICAL ACTIVITY |
8 |
0.0019 |
| 35 |
LUPUS-LIKE SYNDROME |
17 |
0.0019 |
| 36 |
LIVE BIRTH |
13 |
0.0016 |
| 37 |
IMMUNISATION REACTION |
1 |
0.0014 |
| 38 |
MYOPERICARDITIS |
1 |
0.0013 |
| 39 |
COLECTOMY |
7 |
0.0012 |
| 40 |
CARDIAC OUTPUT DECREASED |
1 |
0.0011 |
| 41 |
ILEAL ULCER |
1 |
0.0010 |
| 42 |
STEROID WITHDRAWAL SYNDROME |
1 |
0.0010 |
| 43 |
PHOTOSENSITIVITY REACTION |
16 |
0.0010 |
| 44 |
BRUGADA SYNDROME |
1 |
0.0010 |
| 45 |
ATRIAL TACHYCARDIA |
2 |
0.0010 |
| 46 |
THYROTOXIC CRISIS |
1 |
0.0009 |
| 47 |
LONG QT SYNDROME |
2 |
0.0008 |
| 48 |
PERITONITIS |
17 |
0.0008 |
| 49 |
VENTRICULAR ARRHYTHMIA |
3 |
0.0008 |
| 50 |
INTERVERTEBRAL DISC PROTRUSION |
17 |
0.0008 |
| 51 |
RETINAL DISORDER |
2 |
0.0008 |
| 52 |
RESPIRATORY ACIDOSIS |
3 |
0.0008 |
| 53 |
VENTRICULAR TACHYCARDIA |
12 |
0.0007 |
| 54 |
THYROIDITIS |
2 |
0.0007 |
| 55 |
TORSADE DE POINTES |
5 |
0.0006 |
| 56 |
NEONATAL DISORDER |
1 |
0.0006 |
| 57 |
ASCITES |
18 |
0.0006 |
| 58 |
FREQUENT BOWEL MOVEMENTS |
16 |
0.0006 |
| 59 |
SUPRAVENTRICULAR EXTRASYSTOLES |
2 |
0.0006 |
| 60 |
NYSTAGMUS |
3 |
0.0006 |
| 61 |
DEVICE ALARM ISSUE |
1 |
0.0006 |
| 62 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
19 |
0.0005 |
| 63 |
SINUS BRADYCARDIA |
5 |
0.0005 |
| 64 |
ADRENOCORTICAL INSUFFICIENCY ACUTE |
1 |
0.0005 |
| 65 |
ELECTROCARDIOGRAM QT PROLONGED |
18 |
0.0005 |
| 66 |
INJECTION SITE INDENTATION |
1 |
0.0005 |
| 67 |
VENTRICULAR HYPERTROPHY |
1 |
0.0004 |
| 68 |
VENTRICULAR DYSFUNCTION |
1 |
0.0004 |
| 69 |
COLITIS ULCERATIVE |
17 |
0.0004 |
| 70 |
COGNITIVE DISORDER |
17 |
0.0004 |
| 71 |
VENTRICULAR FIBRILLATION |
4 |
0.0004 |
| 72 |
HEART VALVE INCOMPETENCE |
1 |
0.0003 |
| 73 |
FINE MOTOR SKILL DYSFUNCTION |
1 |
0.0003 |
| 74 |
INJECTION SITE VESICLES |
2 |
0.0003 |
| 75 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
18 |
0.0003 |
| 76 |
LISTLESS |
1 |
0.0003 |
| 77 |
APLASIA PURE RED CELL |
1 |
0.0003 |
| 78 |
BRONCHIOLITIS |
1 |
0.0003 |
| 79 |
PLEURAL EFFUSION |
17 |
0.0003 |
| 80 |
STEVENS-JOHNSON SYNDROME |
6 |
0.0003 |
| 81 |
PROTEIN TOTAL DECREASED |
1 |
0.0003 |
| 82 |
ELECTROLYTE IMBALANCE |
3 |
0.0003 |
| 83 |
TRICUSPID VALVE INCOMPETENCE |
2 |
0.0003 |
| 84 |
RESPIRATORY FAILURE |
18 |
0.0002 |
| 85 |
IMMUNOSUPPRESSION |
2 |
0.0002 |
| 86 |
BLOOD TRIGLYCERIDES INCREASED |
4 |
0.0002 |
| 87 |
BUNDLE BRANCH BLOCK RIGHT |
1 |
0.0002 |
| 88 |
ISCHAEMIA |
1 |
0.0002 |
| 89 |
ARTHRITIS |
17 |
0.0002 |
| 90 |
ATRIAL FIBRILLATION |
21 |
0.0002 |
| 91 |
MATERNAL EXPOSURE DURING PREGNANCY |
19 |
0.0002 |
| 92 |
KIDNEY TRANSPLANT REJECTION |
1 |
0.0002 |
| 93 |
STATUS EPILEPTICUS |
2 |
0.0002 |
| 94 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
1 |
0.0002 |
| 95 |
OLIGURIA |
1 |
0.0002 |
| 96 |
HYPOGAMMAGLOBULINAEMIA |
1 |
0.0002 |
| 97 |
LEFT VENTRICULAR DYSFUNCTION |
1 |
0.0001 |
| 98 |
WRONG PRODUCT ADMINISTERED |
1 |
0.0001 |
| 99 |
EXTRASYSTOLES |
1 |
0.0001 |
| 100 |
DUODENAL ULCER |
1 |
0.0001 |
| 101 |
HYPERTHYROIDISM |
2 |
0.0001 |
| 102 |
HYDRONEPHROSIS |
1 |
0.0001 |
| 103 |
TROPONIN INCREASED |
1 |
0.0001 |
| 104 |
THYROID DISORDER |
2 |
0.0001 |
| 105 |
ELECTROCARDIOGRAM ABNORMAL |
1 |
0.0001 |
| 106 |
ATRIAL FLUTTER |
1 |
0.0001 |
| 107 |
INFECTION |
17 |
0.0001 |
| 108 |
NEUROTOXICITY |
2 |
0.0001 |
| 109 |
HAEMARTHROSIS |
1 |
0.0001 |
| 110 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
1 |
0.0001 |
| 111 |
TREATMENT FAILURE |
9 |
0.0001 |
| 112 |
ARRHYTHMIA |
5 |
0.0001 |
| 113 |
CHOLESTASIS |
2 |
0.0001 |
| 114 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 115 |
MYALGIA |
17 |
0.0001 |
| 116 |
CONTRAINDICATED PRODUCT ADMINISTERED |
3 |
0.0001 |
| 117 |
VENTRICULAR EXTRASYSTOLES |
1 |
0.0001 |
| 118 |
RHABDOMYOLYSIS |
4 |
0.0001 |
| 119 |
RENAL PAIN |
1 |
0.0001 |
| 120 |
PRODUCT PRESCRIBING ISSUE |
2 |
0.0001 |
| 121 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
2 |
0.0001 |
| 122 |
MITRAL VALVE INCOMPETENCE |
1 |
0.0001 |
| 123 |
HYPOXIA |
3 |
0.0001 |
| 124 |
MYOCLONUS |
1 |
0.0001 |
| 125 |
ERYTHEMA |
17 |
0.0001 |
| 126 |
TENDON RUPTURE |
1 |
0.0001 |
| 127 |
PHARYNGITIS |
1 |
0.0001 |
| 128 |
BRADYCARDIA |
4 |
0.0001 |
| 129 |
DRUG INEFFECTIVE |
97 |
0.0001 |
| 130 |
MENTAL STATUS CHANGES |
2 |
0.0001 |
| 131 |
HYPOMAGNESAEMIA |
1 |
0.0001 |
| 132 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 133 |
DEPRESSION |
16 |
0.0001 |
| 134 |
ANOSMIA |
1 |
0.0001 |
| 135 |
CARDIOMYOPATHY |
1 |
0.0001 |
| 136 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 137 |
EJECTION FRACTION DECREASED |
1 |
0.0001 |
| 138 |
THERAPY PARTIAL RESPONDER |
1 |
0.0001 |
| 139 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
| 140 |
COAGULOPATHY |
1 |
0.0001 |
| 141 |
CIRCULATORY COLLAPSE |
1 |
0.0001 |
| 142 |
HEART RATE DECREASED |
2 |
0.0001 |
| 143 |
AGRANULOCYTOSIS |
1 |
0.0001 |
| 144 |
HEPATIC FUNCTION ABNORMAL |
2 |
0.0001 |
| 145 |
HYPOCALCAEMIA |
1 |
0.0001 |
| 146 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 147 |
RIB FRACTURE |
1 |
0.0000 |
| 148 |
PULMONARY HYPERTENSION |
1 |
0.0000 |
| 149 |
JOINT INJURY |
1 |
0.0000 |
| 150 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 151 |
PRODUCT DISPENSING ERROR |
1 |
0.0000 |
| 152 |
MELAENA |
1 |
0.0000 |
| 153 |
LIVER DISORDER |
2 |
0.0000 |
| 154 |
SNEEZING |
1 |
0.0000 |
| 155 |
HYPOKALAEMIA |
2 |
0.0000 |
| 156 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
3 |
0.0000 |
| 157 |
PRESYNCOPE |
1 |
0.0000 |
| 158 |
ARTHRALGIA |
17 |
0.0000 |
| 159 |
LUNG DISORDER |
2 |
0.0000 |
| 160 |
AGEUSIA |
1 |
0.0000 |
| 161 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 162 |
DRUG INTERACTION |
6 |
0.0000 |
| 163 |
EAR INFECTION |
1 |
0.0000 |
| 164 |
CARDIAC FAILURE |
3 |
0.0000 |
| 165 |
OFF LABEL USE |
32 |
0.0000 |
| 166 |
DEMENTIA |
1 |
0.0000 |
| 167 |
DYSSTASIA |
1 |
0.0000 |
| 168 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 169 |
TACHYCARDIA |
3 |
0.0000 |
| 170 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 171 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 172 |
EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 173 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 174 |
HYPOTENSION |
6 |
0.0000 |
| 175 |
HAEMATURIA |
1 |
0.0000 |
| 176 |
DELIRIUM |
1 |
0.0000 |
| 177 |
PRODUCT USE IN UNAPPROVED INDICATION |
7 |
0.0000 |
| 178 |
PAIN |
17 |
0.0000 |
| 179 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 180 |
ACUTE KIDNEY INJURY |
4 |
0.0000 |
| 181 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 182 |
OSTEOPOROSIS |
1 |
0.0000 |
| 183 |
CARDIAC ARREST |
2 |
0.0000 |
| 184 |
FATIGUE |
18 |
0.0000 |
| 185 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 186 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 187 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 188 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 189 |
AGGRESSION |
1 |
0.0000 |
| 190 |
ILLNESS |
2 |
0.0000 |
| 191 |
OEDEMA |
1 |
0.0000 |
| 192 |
ARTHROPATHY |
1 |
0.0000 |
| 193 |
INFLUENZA |
2 |
0.0000 |
| 194 |
THROMBOCYTOPENIA |
2 |
0.0000 |
| 195 |
TOXICITY TO VARIOUS AGENTS |
3 |
0.0000 |
| 196 |
MYOCARDIAL INFARCTION |
3 |
0.0000 |
| 197 |
NASAL CONGESTION |
1 |
0.0000 |
| 198 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 199 |
RHINORRHOEA |
1 |
0.0000 |
| 200 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 201 |
NEUTROPENIA |
2 |
0.0000 |
| 202 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 203 |
MOBILITY DECREASED |
1 |
0.0000 |
| 204 |
BRONCHITIS |
1 |
0.0000 |
| 205 |
CONDITION AGGRAVATED |
4 |
0.0000 |
| 206 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 207 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 208 |
TREMOR |
2 |
0.0000 |
| 209 |
DRUG ABUSE |
1 |
0.0000 |
| 210 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 211 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 212 |
CARDIAC DISORDER |
1 |
0.0000 |
| 213 |
SWELLING |
1 |
0.0000 |
| 214 |
PRODUCT USE ISSUE |
2 |
0.0000 |
| 215 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 216 |
ANAEMIA |
2 |
0.0000 |
| 217 |
PRURITUS |
4 |
0.0000 |
| 218 |
CONTUSION |
1 |
0.0000 |
| 219 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 220 |
SYNCOPE |
1 |
0.0000 |
| 221 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
2 |
0.0000 |
| 222 |
SINUSITIS |
1 |
0.0000 |
| 223 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 224 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 225 |
PNEUMONIA |
3 |
0.0000 |
| 226 |
RASH |
4 |
0.0000 |
| 227 |
SEPSIS |
1 |
0.0000 |
| 228 |
SEIZURE |
1 |
0.0000 |
| 229 |
PALPITATIONS |
1 |
0.0000 |
| 230 |
CHILLS |
1 |
0.0000 |
| 231 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 232 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 233 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 234 |
DEHYDRATION |
1 |
0.0000 |
| 235 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 236 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 237 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 238 |
HOSPITALISATION |
1 |
0.0000 |
| 239 |
VOMITING |
3 |
0.0000 |
| 240 |
FALL |
2 |
0.0000 |
| 241 |
URTICARIA |
1 |
0.0000 |
| 242 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 243 |
COVID-19 |
1 |
0.0000 |
| 244 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 245 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 246 |
SOMNOLENCE |
1 |
0.0000 |
| 247 |
HYPERTENSION |
1 |
0.0000 |
| 248 |
OVERDOSE |
1 |
0.0000 |
| 249 |
CONSTIPATION |
1 |
0.0000 |
| 250 |
DECREASED APPETITE |
1 |
0.0000 |
| 251 |
BACK PAIN |
1 |
0.0000 |
| 252 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 253 |
DIZZINESS |
2 |
0.0000 |
| 254 |
NAUSEA |
3 |
0.0000 |
| 255 |
COUGH |
1 |
0.0000 |
| 256 |
DIARRHOEA |
2 |
0.0000 |
| 257 |
ASTHENIA |
1 |
0.0000 |
| 258 |
HEADACHE |
1 |
0.0000 |
| 259 |
DEATH |
1 |
0.0000 |